Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Wiegel

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
World Journal of Urology|September 21, 2004
Shared decision-making--results from an interdisciplinary consulting service for prostate cancerM Schostak, T Wiegel, M Müller, et al.
Der Pathologe|August 22, 2013
[The importance of pathology in the German prostate cancer study PREFERE]G Kristiansen, M Stöckle, P Albers, et al.
British Journal of Cancer|September 30, 2010
Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-αM Kornmann, L Staib, T Wiegel, et al.
European Radiology|December 6, 2001
Intraocular metastases: differential diagnosis from uveal melanomas with high-resolution MRI using a surface coilA J Lemke, N Hosten, T Wiegel, et al.
AJNR. American Journal of Neuroradiology|October 8, 1998
Choroidal hemangioma: MR findings and differentiation from uveal melanomaC Stroszczynski, N Hosten, N Bornfeld, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 23, 1998
High-dose rate interstitial with external beam irradiation for localized prostate cancer--results of a prospective trialS Dinges, S Deger, S Koswig, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 22, 2012
Neoadjuvant androgen deprivation therapy for prostate volume reduction, lower urinary tract symptom relief and quality of life improvement in men with intermediate- to high-risk prostate cancer: a randomised non-inferiority trial of degarelix versus goserelin plus bicalutamideM Mason, X Maldonado Pijoan, C Steidle, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|February 24, 2017
Response Evaluation in Head and Neck Oncology: Definition and PredictionT K Hoffmann, P J Schuler, S Laban, et al.
Actas Urologicas Espanolas|July 16, 2011
[EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer]N Mottet, J Bellmunt, M Bolla, et al.
Actas Urologicas Espanolas|July 16, 2011
[EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease]A Heidenreich, J Bellmunt, M Bolla, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
World Journal of Urology|September 21, 2004
Shared decision-making--results from an interdisciplinary consulting service for prostate cancerM Schostak, T Wiegel, M Müller, et al.
Der Pathologe|August 22, 2013
[The importance of pathology in the German prostate cancer study PREFERE]G Kristiansen, M Stöckle, P Albers, et al.
British Journal of Cancer|September 30, 2010
Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-αM Kornmann, L Staib, T Wiegel, et al.
European Radiology|December 6, 2001
Intraocular metastases: differential diagnosis from uveal melanomas with high-resolution MRI using a surface coilA J Lemke, N Hosten, T Wiegel, et al.
AJNR. American Journal of Neuroradiology|October 8, 1998
Choroidal hemangioma: MR findings and differentiation from uveal melanomaC Stroszczynski, N Hosten, N Bornfeld, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 23, 1998
High-dose rate interstitial with external beam irradiation for localized prostate cancer--results of a prospective trialS Dinges, S Deger, S Koswig, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 22, 2012
Neoadjuvant androgen deprivation therapy for prostate volume reduction, lower urinary tract symptom relief and quality of life improvement in men with intermediate- to high-risk prostate cancer: a randomised non-inferiority trial of degarelix versus goserelin plus bicalutamideM Mason, X Maldonado Pijoan, C Steidle, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|February 24, 2017
Response Evaluation in Head and Neck Oncology: Definition and PredictionT K Hoffmann, P J Schuler, S Laban, et al.
Actas Urologicas Espanolas|July 16, 2011
[EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer]N Mottet, J Bellmunt, M Bolla, et al.
Actas Urologicas Espanolas|July 16, 2011
[EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease]A Heidenreich, J Bellmunt, M Bolla, et al.
Pageof 8